Anne Eugster

Anne Eugster

Auto-generated profile, based on publicly available information

Anne Eugster

Center for Regenerative Therapies Dresden, Faculty of Medicine, Technische Universität Dresden, Dresden, Germany

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 February 2017 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
AHAnne-Kristin Heninger
Anne-Kristin Heninger
AEAnne Eugster
Anne Eugster
DKDenise Kuehn
Denise Kuehn
FBFlorian Buettner
Florian Buettner
MKMatthias Kuhn
Matthias Kuhn
EBEzio Bonifacio
Ezio Bonifacio
A divergent autoantigen-responsive CD4+T cell population is present in infancy, before autoimmunity in type 1 diabetes.

26 May 2021 in eLife
Verified
Journal Article
Open access
JTJohannes Trück
Johannes Trück
AEAnne Eugster
Anne Eugster
PBPierre Barennes
Pierre Barennes
CTChristopher M Tipton
Christopher M Tipton
EPEline T Luning Prak
Eline T Luning Prak
EMEncarnita Mariotti-Ferrandiz
Encarnita Mariotti-Ferrandiz
Use of adaptive immune receptor repertoire sequencing (AIRR-seq) has become widespread, providing new insights into the immune system with potential broad clinical and diagnostic applications. However, like many high-throughput technologies, it comes with several problems, and the AIRR Community was established to understand and help solve them. We, the AIRR Community’s Biological Resources Working Group, have surveyed scientists about the need for standards and controls in generating and annotating AIRR-seq data. Here, we review the current status of AIRR-seq, provide the results of our survey, and based on them, offer recommendations for developing AIRR-seq standards and controls, including future work.

29 October 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
AEAnne Eugster
Anne Eugster
ALAnna Lorenc
Anna Lorenc
MKMartin Kotrulev
Martin Kotrulev
YKYogesh Kamra
Yogesh Kamra
MGManisha Goel
Manisha Goel
IGIria Gomez-Tourino
Iria Gomez-Tourino
Autoimmune diseases result from autoantigen-mediated activation of adaptive immunity; intriguingly, autoantigen-specific T cells are also present in healthy donors. An assessment of dynamic changes of this autoreactive repertoire in both health and disease is thus warranted. Here we investigate the physiological versus pathogenic autoreactive processes in the context of Type 1 diabetes (T1D) and one of its landmark autoantigens, glutamic acid decarboxylase 65 (GAD65). Using single cell gene expression profiling and tandem T cell receptor (TCR) sequencing, we find that GAD65-specific true naïve cells are present in both health and disease, with GAD65-specific effector and memory responses showing similar ratios in healthy donors and patients. Deeper assessment of phenotype and TCR repertoire uncover differential features in GAD65-specific TCRs, including lower clonal sizes of healthy donor-derived clonotypes in patients. We thus propose a model whereby physiological autoimmunity against GAD65 is needed during early life, and that alterations of these physiological autoimmune processes in predisposed individuals trigger overt Type 1 diabetes.

2 March 2022 in Immunology
Verified
Journal Article
Open access
PDF file
JRJulia Reinhardt
Julia Reinhardt
VSVirag Sharma
Virag Sharma
ASAntigoni Stavridou
Antigoni Stavridou
ALAnnett Lindner
Annett Lindner
SRSusanne Reinhardt
Susanne Reinhardt
AEAnne Eugster
Anne Eugster
Resting conventional T cells (Tconv) can be distinguished from T regulatory cells (Treg) by the canonical markers FOXP3, CD25 and CD127. However, the expression of these proteins alters after T‐cell activation leading to overlap between Tconv and Treg. The objective of this study was to distinguish resting and antigen‐responsive T effector (Tconv) and Treg using single‐cell technologies. CD4+ Treg and Tconv cells were stimulated with antigen and responsive and non‐responsive populations processed for targeted and non‐targeted single‐cell RNAseq. Machine learning was used to generate a limited set of genes that could distinguish responding and non‐responding Treg and Tconv cells and which was used for single‐cell multiplex qPCR and to design a flow cytometry panel. Targeted scRNAseq clearly distinguished the four‐cell populations. A minimal set of 27 genes was identified by machine learning algorithms to provide discrimination of the four populations at >95% accuracy. In all, 15 of the genes were validated to be differentially expressed by single‐cell multiplex qPCR. Discrimination of responding Treg from responding Tconv could be achieved by a flow cytometry strategy that included staining for CD25, CD127, FOXP3, IKZF2, ITGA4, and the novel marker TRIM which was strongly expressed in Tconv and weakly expressed in both responding and non‐responding Treg. A minimal set of genes was identified that discriminates responding and non‐responding CD4+ Treg and Tconv cells and, which have identified TRIM as a marker to distinguish Treg by flow cytometry.

1 March 2018 in Clinical Immunology
Verified
Journal Article
Open access
JKJan Knoop
Jan Knoop
AGAnita Gavrisan
Anita Gavrisan
DKDenise Kuehn
Denise Kuehn
JRJulia Reinhardt
Julia Reinhardt
MHMelanie Heinrich
Melanie Heinrich
EBEzio Bonifacio
Ezio Bonifacio
The phenotype of autoreactive T cells in type 1 diabetes is described as Th1, Th17 and/or Th21, but is largely uncharacterized. We combined multi-parameter cytokine profiling and proliferation, and identified GM-CSF producing cells as a component of the response to beta cell autoantigens proinsulin and GAD65. Overall cytokine profiles of CD4+ T cell were not altered in type 1 diabetes. In contrast, patients with recent onset type 1 diabetes had increased frequencies of proinsulin-responsive CD4+CD45RA- T cells producing GM-CSF (p=0.002), IFNγ (p=0.004), IL-17A (p=0.008), IL-21 (p=0.011), and IL-22 (p=0.007), and GAD65-responsive CD4+CD45RA- T cells producing IL-21 (p=0.039). CD4+ T cells with a GM-CSF+IFNγ-IL-17A-IL-21-IL-22- phenotype were increased in patients for responses to both proinsulin (p=0.006) and GAD65 (p=0.037). GM-CSF producing T cells are a novel phenotype in the repertoire of T helper cells in type 1 diabetes and consolidate a Th1/Th17 pro-inflammatory pathogenesis in the disease.

1 August 1993 in Journal of the American Veterinary Medical Association
Verified
Journal Article
Open access
PDF file
BABruce Abbitt
Bruce Abbitt
TCThomas M. Craig
Thomas M. Craig
LJLarry P. Jones
Larry P. Jones
RHRichard L. Huey
Richard L. Huey
AEA. Konrad Eugster
A. Konrad Eugster
"Protozoal abortion in a herd of cattle concurrently infected with Hammondia pardalis" published on 01 Aug 1993 by American Veterinary Medical Association.